Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sandoz Group AG Sponsored ADR (SDZNY : OTC)

• Company Description    Sandoz Group AG develops, manufactures and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars and biotechnology manufacturing services and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Sandoz Group AG is based in Rotkreuz, Switzerland. Number of Employees: 23,406

• Price / Volume Information    Yesterday's Closing Price: $56.00 Daily Weekly Monthly 20 Day Moving Average: 19,256 shares Shares Outstanding: 440.00 (millions) Market Capitalization: $24,640.00 (millions) Beta: 0.60 52 Week High: $56.37 52 Week Low: $35.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 4.95% 1.02% 12 Week 39.17% 17.06% Year To Date 38.27% 29.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Forum 1 Novartis Campus - Basel,V8 CH-4056 CHE ph: 41-61-324-1111 fax: - investor.relations@sandoz.com http://www.sandoz.com

• General Corporate Information    Officers Richard Saynor - Chief Executive Officer Gilbert Ghostine - Chairman Karen J. Huebscher - Vice-Chair Remco Steenbergen - Chief Financial Officer Francisco Ballester - President Peer Information Sandoz Group AG Sponsored ADR (GSAC) Sandoz Group AG Sponsored ADR (CASI) Sandoz Group AG Sponsored ADR (ALCD.) Sandoz Group AG Sponsored ADR (OMNN) Sandoz Group AG Sponsored ADR (CGPI.) Sandoz Group AG Sponsored ADR (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 799926100 SIC: 8880 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 440.00 Most Recent Split Date: (:1) Beta: 0.60 Market Capitalization: $24,640.00 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.78% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.44 Current Fiscal Year EPS Consensus Estimate: $3.15 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 18.35% Last Dividend Paid: 04/22/2025 - $0.44 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: 17.78 Trailing 12 Months: - PEG Ratio: 0.97 Price Ratios Price/Book: 3.02 Price/Cash Flow: 20.95 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.24 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 0.79 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -0.11 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 18.56 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 1.95 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.57 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 36.37

Powered by Zacks Investment Research ©